U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Screw-in drug eluting lead

Patent 4953564 Issued on September 4, 1990. Estimated Expiration Date: Icon_subject August 23, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

H356

Transvenously implantable lead
Patent #: 4106512
Issued on: 08/15/1978
Inventor: Bisping

Stylet insertion guide and rotation control device for use with body implantable lead
Patent #: 4209019
Issued on: 06/24/1980
Inventor: Dutcher ,   et al.

Body-implantable lead with protected, extendable tissue securing means
Patent #: 4217913
Issued on: 08/19/1980
Inventor: Dutcher

Drug dispensing body implantable lead
Patent #: 4506680
Issued on: 03/26/1985
Inventor: Stokes

Drug dispensing body implantable lead employing molecular sieves and methods of fabrication
Patent #: 4577642
Issued on: 03/25/1986
Inventor: Stokes

Method of making a drug dispensing body
Patent #: 4606118
Issued on: 08/19/1986
Inventor: Cannon ,   et al.

Introducer tool for screw-in lead
Patent #: 4624266
Issued on: 11/25/1986
Inventor: Kane

Body implantable lead
Patent #: 4711251
Issued on: 12/08/1987
Inventor: Stokes

Positive fixation cardiac electrode with drug elution capabilities Patent #: 4819661
Issued on: 04/11/1989
Inventor: Heil, Jr. ,   et al.

Inventor

Assignee

Application

No. 398199 filed on 08/23/1989

US Classes:

607/120, With drug or medicament-dispensing600/375, Anchored607/127, Axially-mounted helical type607/128Retractable tines or hooks

Examiners

Primary: Cohen, Lee S.
Assistant: Getzow, S.

Attorney, Agent or Firm

International Class

A61N 001/05

Abstract

A cardiac pacing lead or other stimulation lead carrying a drug incorporated into a controlled release device. The lead is provided with an extendable fixation helix which is advanceable from the distal end of the lead in order to engage with the tissue to be stimulated and to maintain the distal end of the lead adjacent the tissue to be stimulated. The controlled release device is located within the fixation helix and is extended with the fixation helix when it is advanced out of the distal end of the lead. In its advanced position, the controlled release device is positioned adjacent the distal end of the lead, preferably in a position to contact the tissue to be stimulated.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?